Understanding the pharmacokinetics of hormone replacement therapy medications is vital for healthcare providers to make informed decisions on dosage, administration frequency, and monitoring, thereby contributing to effective, individualized hormone replacement therapy (20)
Its weight loss application was later studied and approved under the brand name Wegovy at a higher dose
Skin wound studies show accelerated closure, reduced scarring, and improved structural integrity of healed tissue
Future research should focus on developing strategies for selective targeting to minimize effects on normal tissues, understanding mechanisms of resistance and ways to overcome them, and optimizing combination therapies with chemotherapy, radiotherapy, or immunotherapy to enhance efficacy
Current approved treatments, including acetylcholinesterase inhibitors and the N -methyl- D -aspartate receptor (NMDAR) antagonist memantine, offer only modest symptomatic relief without altering disease progression
Without clinical studies, the assumption that these forms are therapeutically equivalent remains unproven